AI Mutational Signature Cancer Type Classification

Deep Learning Architectures for Mutational Signature Deconvolution

This research investigates advanced neural network architectures including transformers and graph neural networks for decomposing complex mutational signatures into constituent exposure patterns. The work produces novel computational methods that improve signature resolution accuracy and enable identification of previously undetectable carcinogenic processes.

Single-Cell Sequencing Integration with AI Classification Models

This research explores machine learning approaches to classify cancer types from single-cell mutational data and heterogeneous cell populations. The study generates insights into intra-tumoral heterogeneity and reveals cancer-specific mutational patterns at cellular resolution.

Interpretable Machine Learning for Signature Feature Attribution

This research develops explainable AI methods such as SHAP and attention mechanisms to identify which mutational features most strongly associate with cancer type classification. The contribution establishes trustworthy AI frameworks that reveal mechanistic relationships between specific mutations and cancer phenotypes.

Multi-Modal Data Fusion Combining Genomic and Clinical Features

This research investigates integration of mutational signatures with clinical metadata, imaging data, and molecular biomarkers using advanced fusion algorithms. The discovery produces enriched predictive models that achieve superior cancer type classification and prognostic stratification.

Transfer Learning Across Cancer Cohorts and Sequencing Platforms

This research examines domain adaptation and transfer learning techniques to generalize mutational signature classifiers across disparate patient cohorts and sequencing technologies. The work addresses critical challenges in model portability and generates insights for building robust cross-institutional AI systems.

Rare Cancer Type Classification Using Few-Shot Learning Paradigms

This research applies meta-learning and few-shot learning approaches to classify rare cancer types with limited mutational signature training examples. The advancement enables accurate identification of understudied cancers and expands the applicability of AI classification to underrepresented malignancies.

Contextual Mutational Signature Modeling with Sequence Embeddings

This research develops contextualized embedding representations that capture nucleotide triplet contexts and genomic positional information for mutational signature analysis. The contribution produces richer feature representations that improve cancer type discrimination and reveal context-dependent mutational processes.

Uncertainty Quantification and Bayesian Classification for Cancer Subtyping

This research implements Bayesian neural networks and probabilistic frameworks to quantify prediction uncertainty in mutational signature-based cancer classification. The advancement enables clinical confidence intervals and identifies ambiguous cases requiring additional molecular characterization.

Adversarial Robustness Testing of Mutational Signature Classifiers

This research investigates adversarial perturbations and robustness vulnerabilities in AI models trained on mutational signatures to identify failure modes. The study generates critical safety insights for clinical deployment and develops hardened architectures resistant to distribution shifts.

Temporal Evolution Tracking of Mutational Signatures During Cancer Progression

This research develops recurrent neural networks and temporal sequence models to track dynamic changes in mutational signatures across longitudinal tumor samples and treatment stages. The discovery reveals cancer evolution patterns and produces predictive models for treatment response and acquired resistance.